Christian D. DeMoya

Christian D. DeMoya

Auto-generated profile, based on publicly available information

Christian D. DeMoya

Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
CDChristian D. DeMoya
Christian D. DeMoya
AJAnisha Joenathan
Anisha Joenathan
TLTaylor B. Lawson
Taylor B. Lawson
DFDavid T. Felson
David T. Felson
Thomas P SchaerThomas P Schaer
Thomas P Schaer
MGMark Grinstaff
Mark Grinstaff

19 February 2020 in Journal of Immunology and Regenerative Medicine
Verified
Journal Article
Closed access
RLRicardo Londono
Ricardo Londono
STSean Tighe
Sean Tighe
BMBeatrice Milnes
Beatrice Milnes
CDChristian DeMoya
Christian DeMoya
LQLina Maria Quijano
Lina Maria Quijano
Thomas P LozitoThomas P Lozito
Thomas P Lozito

3 April 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
TLTaylor B. Lawson
Taylor B. Lawson
AJAnisha Joenathan
Anisha Joenathan
CDChristian D. DeMoya
Christian D. DeMoya
LZLiangwei Zheng
Liangwei Zheng
YZYiding Zhong
Yiding Zhong
MGMark Grinstaff
Mark Grinstaff

12 October 2023 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
BCBenjamin G. Cooper
Benjamin G. Cooper
CDChristian D. DeMoya
Christian D. DeMoya
KSKatie J. Sikes
Katie J. Sikes
DFDavid D. Frisbie
David D. Frisbie
NPNikki Phillips
Nikki Phillips
MGMark Grinstaff
Mark Grinstaff
We report the relationships between linear vs. network polymer architecture and biomechanical outcomes including lubrication and cushioning when the polymers are applied to the surface of articulating knee cartilage.

15 December 2025 in Acta Biomaterialia
Verified
Journal Article
Closed access
CDChristian D. DeMoya
Christian D. DeMoya
PHPierson Husted
Pierson Husted
DMDev R. Mehrotra
Dev R. Mehrotra
MAMichael B. Albro
Michael B. Albro
BSBrian D. Snyder
Brian D. Snyder
MGMark Grinstaff
Mark Grinstaff

22 October 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
KSKaitlynn Sockett
Kaitlynn Sockett
MLMadeline Loffredo
Madeline Loffredo
CDChristian DeMoya
Christian DeMoya
ZGZoe Garman
Zoe Garman
MGMark Grinstaff
Mark Grinstaff
Hyaluronic acid (HA) binds the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis. Approaches to target CD44 utilize biologically sourced HA which inherently suffers from molecular weight (Mw) heterogeneity and biological contaminants. Fully synthetic approaches to HA are attractive and circumvent these biological contaminants; however, readily accessing oligomers of six monosaccharides or more, as is required for CD44 binding, is challenging. To this end, we report the synthesis of carbohydrate-based glycopolymers functionalized with HA disaccharide pendant chains. These well-defined and chemoselective polymers consist of glucose monomers linked via -1,2 amide bonds, termed polyamidosaccharides, functionalized with branched HA disaccharide moieties interspersed throughout via a strain-promoted azide-alkyne cycloaddition. Among these homopolymers and copolymers, two of the polymers bearing the highest HA disaccharide conjugation bind CD44 with nanomolar affinity. Assays using a rhodamine-labeled polymer reveal a positive relationship between cellular internalization and CD44 expression levels in breast cancer cells. Conjugation of paclitaxel to the polymer results in enhanced paclitaxel efficacy in CD44-expressing cancer cells compared to free paclitaxel.